Dorsey Wright & Associates Bristol Myers Squibb CO Transaction History

Dorsey Wright & Associates

  • $408 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 28, 2020
SELL
$57.43 - $63.64 $1.6 Million - $1.77 Million
-27,876 Closed
0 $0
Q2 2020

Jul 23, 2020
SELL
$54.82 - $64.09 $132,280 - $154,649
-2,413 Reduced 7.97%
27,876 $1.64 Million
Q1 2020

Apr 20, 2020
BUY
$46.4 - $67.43 $1.41 Million - $2.04 Million
30,289 New
30,289 $1.69 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email